NAVI
18
-6
PFE
19
-5
CTSH
47
7
CME
42
5
PRGO
35
-4
FRT
50
-5
TRIP
55
-2
APH
61
2
MRK
46
-4
PHM
54
5
APA
39
-5
GT
33
-4
EMC
38
-2
FOXA
57
-3
UNM
38
-16
STX
69
-5
COP
50
-3
MOS
53
-5
SPG
40
-5
SLG
39
-6
NAVI
18
-6
PFE
19
-5
CTSH
47
7
CME
42
5
PRGO
35
-4
FRT
50
-5
TRIP
55
-2
APH
61
2
MRK
46
-4
PHM
54
5
APA
39
-5
GT
33
-4
EMC
38
-2
FOXA
57
-3
UNM
38
-16
STX
69
-5
COP
50
-3
MOS
53
-5
SPG
40
-5
SLG
39
-6
Financhill
Back

Greek Organisation of Football Prognostics SA Vs. Cidara Therapeutics Industry Stock Comparison

Buy
52

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:
$11.15
Seasonality Move:
-0.07%
Buy
69

CDTX
Cidara Therapeutics

Last Price:
$62.12
Seasonality Move:
-9.13%
Buy
52
Greek Organisation of Football Prognostics SA (GOFPY) is a Buy

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

  • The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.86. The Score for GOFPY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

  • The current Cidara Therapeutics [CDTX] share price is $61.79. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

  • The Greek Organisation of Football Prognostics SA share price today is $10.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

  • The Cidara Therapeutics share price today is $61.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.

GOFPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.54 Buy
Relative Strength Index (14 RSI): 39.67 Sell
Chaikin Money Flow: -24713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.07 - 11.55) Sell
Bollinger Bands (100): (10.06 - 11.52) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.74 Buy
Relative Strength Index (14 RSI): 68.87 Buy
Chaikin Money Flow: -161750 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.69 - 60.27) Buy
Bollinger Bands (100): (15.59 - 45.13) Buy

GOFPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.06 Sell
20-day SMA: 11.29 Sell
50-day SMA: 11.22 Sell
200-day SMA: 9.61 Buy
8-day EMA: 4.3 Buy
20-day EMA: 1.98 Buy
50-day EMA: 0.84 Buy
200-day EMA: 0.22 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.81 Sell
20-day SMA: 55.87 Buy
50-day SMA: 40.09 Buy
200-day SMA: 24.77 Buy
8-day EMA: 24.44 Buy
20-day EMA: 11.22 Buy
50-day EMA: 4.76 Buy
200-day EMA: 1.22 Buy

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):